In colon cancer, increased levels of Gal-3 coincide with decreased E-cadherin expression [150] and treatment of colon cancer cell lines with recombinant Gal-3 promotes EMT characterized by increased cell migration and invasion [150, 179]. This evidence concerns the gene CDH1 and malignant colon neoplasm.